With new coronavirus variants on the U.S. pandemic scene, experts say brace yourself for another surge — and mask up.

A biology-based mathematical model indicates why COVID-19 outcomes vary widely and how therapy can be tailored to match the needs of specific patient groups.

Mortality rate after cancer surgery drops during 10-year period, but gap persists between Black and white patients.

Researchers have found that a targeted therapy with tocilizumab reduced mortality by 30 percent for critically ill COVID-19 patients when administered within the first two days of ICU admission.

The TestBoston study will facilitate at-home testing on 10,000 people for both the SARS-CoV-2 virus and antibodies against it to increase access to testing and surveillance.

“Viral history” tool VirScan offers new insights into antibody response to SARS-CoV-2.

Highly detailed map of the human heart could guide personalized heart treatments.

Researchers have developed a synthetic lining that could deliver drugs in a sustained way to the small intestine, offering hope for those suffering from lactose intolerance, diabetes, and obesity.

Shifting the U.S.'s COVID-19 testing strategy to emphasize inexpensive, daily tests would break national transmission chains within weeks, an infectious disease testing expert said.

New quantum-classical algorithm brings nuclear magnetic resonance readings closer to “near-term” quantum computing.